0001179110-16-024907.txt : 20160517
0001179110-16-024907.hdr.sgml : 20160517
20160517184058
ACCESSION NUMBER: 0001179110-16-024907
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160513
FILED AS OF DATE: 20160517
DATE AS OF CHANGE: 20160517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE INC
DATE OF NAME CHANGE: 19940719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAFFIERI MICHAEL DAVID
CENTRAL INDEX KEY: 0001604063
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 161658913
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
4
1
edgar.xml
FORM 4 -
X0306
4
2016-05-13
0
0000927066
DAVITA HEALTHCARE PARTNERS INC.
DVA
0001604063
STAFFIERI MICHAEL DAVID
C/O DAVITA HEALTHCARE PARTNERS INC.
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
COO, Kidney Care
Common Stock
2016-05-16
4
S
0
4934
75.6884
D
12279
D
Stock Appreciation Rights
75.42
2016-05-13
4
A
0
66477
0
A
2019-05-13
2021-05-13
Common Stock
66477
66477
D
Represents the weighted average sale price of $75.6884. The range of prices for the sale of these shares was $75.22 - $75.91, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This amount includes 330 shares acquired under Issuer's employee stock purchase plan on 12/31/2015.
The Stock Appreciation Rights were granted on 5/13/2016. 50% will vest on 5/13/2019 and the remaining 50% will vest on 5/13/2020.
/s/ Arturo Sida, Attorney-in-Fact for Michael D. Staffieri
2016-05-17